Information for institutional quotation
Dulaglutide: price, documentation and dispatch in Colombia
Dulaglutide is in Peptidos Colombia's catalog as a research and laboratory-work reference, not intended for human use. Technically, it is a fusion protein joining a GLP-1 analog with an immunoglobulin G4 Fc fragment, a molecular architecture distinct from other references in the same metabolic group, which includes dual and triple incretin-receptor agonists and small molecules with no peptide structure. The available presentations are 5 mg and 10 mg, both lyophilized powder under the criterion the catalog already applies to specifications declared by mass. Lot identity and purity are not assumed from the name: they are confirmed by the certificate of analysis issued by Janoshik Analytical, per lot, with HPLC for purity and mass spectrometry for identity, upon institutional request. The scope of this listing is strictly documentary and B2B quoting.
Presentations and visible prices
| Presentation | Code | Reference price |
|---|---|---|
| 5mg | * | US$336 |
| 10mg | * | US$579 |
The price above is the public value per vial. Availability and batch documentation are confirmed before the quotation is accepted.
Dulaglutide: a fusion protein, not a simple peptide
Dulaglutide's structural classification — a fusion protein of a GLP-1 analog with an IgG4 Fc fragment — sets it apart from a simple short-chain peptide. The Fc fragment is the portion that, in an immunoglobulin, recognizes immune-system receptors; here it is declared joined to the GLP-1 analog as part of the molecular architecture published in the catalog, with this listing describing no consequence of that joining beyond the structural classification.
This description is one of classification, not of composition verified lot by lot. The catalog declares the reference's molecular architecture; the specific lot's certificate of analysis is the document that confirms identity and purity of the vial actually shipped. Both pieces of data coexist in the purchase file without replacing one another.
The catalog's metabolic axis and its seven neighboring references
Dulaglutide shares a technical category with Tirzepatide and Retatrutide, synthetic dual and triple incretin-receptor agonists; with Cagrilintide, a synthetic amylin analog; with AOD9604 and Adipotide, fragments and peptidomimetics derived from other proteins; and with 5-Amino-1MQ and SLU-PP-332, two small molecules the catalog expressly declares as non-peptide. Seven distinct architectures coexist under the same commercial metabolic-research category.
Compared with the dual or triple agonists in the same category, Dulaglutide is distinguished by solving its design through protein fusion with an Fc fragment, rather than through a modified synthetic peptide. This is a molecular-engineering difference the catalog declares for each reference; neither approach is described here in terms of consequence, only classification.
Powder presentation: two sizes of Dulaglutide
Dulaglutide's 5 mg and 10 mg presentations are declared by mass, which corresponds to a lyophilized powder in a vial under the same criterion the catalog uses for the rest of its metabolic references.
Each presentation's current price is shown in the listing's commercial block and should be confirmed there before quoting, without assuming it matches another metabolic reference in the same catalog or an earlier inquiry.
The Janoshik Analytical COA and what does not appear on this listing
Dulaglutide's identity and purity are confirmed by the lot's certificate of analysis, issued by Janoshik Analytical, with HPLC for purity and mass spectrometry for identity. The COA is handled upon institutional request and subject to documentary availability; this listing does not advance a purity figure because that data depends on the specific lot shipped, not on the reference in general.
CAS number, molecular formula, molecular weight, and amino-acid sequence do not appear on this page. For a fusion protein like Dulaglutide, those fields would require specific documentary support that does not exist in this catalog today; they remain visibly pending rather than being filled in by resemblance to another reference in the metabolic axis.
Cold chain and shipping rates within Colombia
Dulaglutide's storage follows the documentation applicable to the lot, currently stated as 2–8 °C, protected from light. Before the order arrives, the receiving institution can prepare that storage space and designate who will log the vial's arrival, so the material is not left without an assigned location at the time of delivery.
Shipping rates to Bogotá and to other domestic destinations are published on the site's shipping information page. Delivery time is confirmed at the time of the quote, according to destination and agreed coordination, and is kept separate from the reference's price in the final estimate. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.
Institutional quote before any payment
An order for Dulaglutide is logged first; the institutional quote confirms in writing the presentation, price, destination, and payment method, and only then is the corresponding payment coordinated. The page does not process an automatic charge when a presentation is selected.
The purchase file brings together the request, the accepted quote, proof of payment, shipping confirmation, receipt, and the lot's COA when requested. This documentary sequence is the same one applied across the rest of the technical catalog, and for Dulaglutide it is worth following with the same care as any other reference before authorizing payment.
Frequently asked questions about Dulaglutide
What is Dulaglutide, technically, in this catalog?
A fusion protein of a GLP-1 analog with an IgG4 Fc fragment. It is offered exclusively for research and laboratory work, not intended for human use.
What other references share its category?
Tirzepatide, Retatrutide, Cagrilintide, AOD9604, Adipotide, 5-Amino-1MQ, and SLU-PP-332, within the catalog's metabolic-research category.
Does Dulaglutide share a structural classification with Tirzepatide or Retatrutide?
No. Dulaglutide is a fusion protein with an IgG4 Fc fragment; Tirzepatide and Retatrutide are synthetic dual and triple incretin-receptor agonists. They share a commercial category, not a molecular architecture.
Who certifies the lot's identity and purity?
Janoshik Analytical, per lot, with HPLC for purity and mass spectrometry for identity, upon institutional request.
How is Dulaglutide stored before laboratory use?
According to the documentation applicable to the lot, currently in a range of 2–8 °C, protected from light, incorporated into the receiving party's custody record.